KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 116 filers reported holding KURA ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $471,000 | +91.5% | 47,363 | +164.3% | 0.25% | +762.1% |
| Q4 2019 | $246,000 | -46.6% | 17,922 | -41.0% | 0.03% | -50.8% |
| Q3 2019 | $461,000 | -22.9% | 30,400 | 0.0% | 0.06% | +43.9% |
| Q2 2019 | $598,000 | -44.3% | 30,400 | -53.0% | 0.04% | -18.0% |
| Q1 2019 | $1,073,000 | +276.5% | 64,700 | +296.9% | 0.05% | +212.5% |
| Q3 2018 | $285,000 | +26.7% | 16,300 | +31.5% | 0.02% | +23.1% |
| Q2 2018 | $225,000 | -81.2% | 12,400 | -80.6% | 0.01% | -82.9% |
| Q1 2018 | $1,196,000 | – | 63,800 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |